Drug Trial Radar · NCT04276883
Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder
Last checked: Nov 20, 2026Latest source record: Aug 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
380
Actual
Start
Feb 24, 2020
Primary completion
May 21, 2020
Study completion May 21, 2020
Sponsor
- Lead sponsor
- BioXcel Therapeutics IncIndustry
- Sponsor type
- Industry
- Collaborators
- Cognitive Research Corporation
- First posted
- Feb 19, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a definitive study to support the safety and efficacy evaluation of BXCL501 for the acute treatment of agitation in bipolar disorder. The BXCL501-302 study is designed to characterize the efficacy, safety and tolerability of BXCL501 (sublingual film formulation of DEX, HCl) in agitation associated with bipolar disorder.
Conditions
- Agitation Associated With Bipolar Disorder
- Agitation,Psychomotor
- Bipolar Disorder
Interventions
Sublingual film containing Dexmedetomidine (BXCL501)Drug
Sublingual film containing Dexmedetomidine (BXCL501)
Placebo FilmDrug
Placebo Film for BXCL501
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the Positive and Negative Syndrome Scale- Excited Component (PEC) Total ScoreTime frame: Baseline and 120 minutes
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
BioXcel Clinical Research Site
Little Rock, Arkansas
BioXcel Clinical Research Site
Cerritos, California
BioXcel Clinical Research Site
Culver City, California
BioXcel Clinical Research Site
Long Beach, California
BioXcel Clinical Research Site
Orange, California
BioXcel Clinical Research Site
Miami Lakes, Florida
BioXcel Clinical Research Site
Chicago, Illinois
BioXcel Clinical Research Site
Gaithersburg, Maryland
BioXcel Clinical Research Site
Las Vegas, Nevada
BioXcel Clinical Research Site
Berlin, New Jersey
BioXcel Clinical Research Site
Marlton, New Jersey
BioXcel Clinical Research Site
Charleston, South Carolina
BioXcel Clinical Research Site
Austin, Texas
BioXcel Clinical Research Site
DeSoto, Texas
BioXcel Clinical Research Site
Richardson, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.